213 related articles for article (PubMed ID: 16096380)
1. Molecular diagnostics in central nervous system tumors.
Fuller CE; Perry A
Adv Anat Pathol; 2005 Jul; 12(4):180-94. PubMed ID: 16096380
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in tumors of the central nervous system - a review.
Scheie D; Kufaishi HHA; Broholm H; Lund EL; de Stricker K; Melchior LC; Grauslund M
APMIS; 2019 May; 127(5):265-287. PubMed ID: 30740783
[TBL] [Abstract][Full Text] [Related]
3. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
[TBL] [Abstract][Full Text] [Related]
4. Oligodendroglial tumors: diagnostic and molecular pathology.
Rodriguez FJ; Giannini C
Semin Diagn Pathol; 2010 May; 27(2):136-45. PubMed ID: 20860317
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathogenesis of oligodendroglial tumors.
Jeuken JW; von Deimling A; Wesseling P
J Neurooncol; 2004 Nov; 70(2):161-81. PubMed ID: 15674476
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications.
Smith JS; Jenkins RB
Front Biosci; 2000 Jan; 5():D213-31. PubMed ID: 10702383
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic histopathology, cytogenetics, and molecular markers of pediatric brain tumors.
Schofield DE
Neurosurg Clin N Am; 1992 Oct; 3(4):723-38. PubMed ID: 1327339
[TBL] [Abstract][Full Text] [Related]
8. Genetics of nervous system tumors.
Shapiro JR
Hematol Oncol Clin North Am; 2001 Dec; 15(6):961-77. PubMed ID: 11770302
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
[TBL] [Abstract][Full Text] [Related]
10. Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.
Perry A
Adv Anat Pathol; 2001 Jul; 8(4):183-99. PubMed ID: 11444508
[TBL] [Abstract][Full Text] [Related]
11. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
[TBL] [Abstract][Full Text] [Related]
12. Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors.
Sato K; Schäuble B; Kleihues P; Ohgaki H
Int J Cancer; 1996 May; 66(3):305-8. PubMed ID: 8621248
[TBL] [Abstract][Full Text] [Related]
13. A review of primary central nervous system neoplasms of cats.
Rissi DR
Vet Pathol; 2023 May; 60(3):294-307. PubMed ID: 36803009
[TBL] [Abstract][Full Text] [Related]
14. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
Hirose T; Ishizawa K; Shimada S
Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic study of intracranial tumors].
Rey JA; Bello MJ; Campos JM; Boixados JR; Sánchez Cascos A
Rev Esp Oncol; 1983; 30(4):469-75. PubMed ID: 6599911
[TBL] [Abstract][Full Text] [Related]
16. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
17. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors.
Takei H; Bhattacharjee MB; Rivera A; Dancer Y; Powell SZ
Arch Pathol Lab Med; 2007 Feb; 131(2):234-41. PubMed ID: 17284108
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
[TBL] [Abstract][Full Text] [Related]
19. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
[TBL] [Abstract][Full Text] [Related]
20. [Selected biomarkers in the primary tumors of the central nervous system: short review].
Rychlý B; Grossmann P; Steňo A; Pataky F
Cesk Patol; 2012 Apr; 48(2):65-71. PubMed ID: 22716052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
